Clinical, virological and histopathological features: Long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni

Liver

Volumn 20, Issue 4, 2000, Pages 281-289

  Kamal, Sanaa ^a,b   Madwar, Mohamed ^b   Bianchi, Leonardo ^c   Tawil, Ahmed E L ^d   Fawzy, Ragaa ^d   Peters, Thomas ^a   Rasenack, Jens W F ^a,e  

^a UNIVERSITY OF FREIBURG   (Germany)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c UNIVERSITY OF BASEL   (Switzerland)

^d AIN SHAMS UNIVERSITY   (Egypt)

^e UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Chronic liver disease; Hepatitis; Liver pathology; Schistosomiasis

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; BLOOD ANALYSIS; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; EGYPT; ENDOSCOPY; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; IMMUNOLOGY; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PORTAL HYPERTENSION; PREVALENCE; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; VIROLOGY;

ADULT; ANIMALS; CD4-CD8 RATIO; EGYPT; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER DISEASES, PARASITIC; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, VIRAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 0033943125     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2000.020004281.x     Document Type: Article

References (49)

1. Schistosomiasis mansoni in Egypt
2. Blood flukes (schistosomes) and liver flukes
3. Hepatosplenic schistosomiasis: A clinical review
4. Hepatic schistosomiasis
5. Systemic and splanchnic hemodynamic changes in patients with schistosomiasis
6. Hepatosplenic schistosomiasis. Pathophysiology and treatment
7. Dynamics of the human immune response to schistosomes
8. Immunological aspects of schistosomiasis
9. Hepatitis C virus: Epidemiology and transmission
10. High HCV prevalence in Egyptian blood donors
11. Prevalence of hepatitis C virus among non-A, non-B-related chronic liver disease in Egypt
12. High seroprevalence of hepatitis C infection among risk groups in Egypt
13. Hepatitis C virus infection in Egyptian blood donors
14. Incidence of hepatitis C virus in Egyptians
15. Chronic liver disease in Alexandria governorate, Egypt: Contribution of schistosomiasis and hepatitis virus infections
16. Hepatitis C virus genotypes: An investigation of type-specific differences in geographic origin and disease
17. Natural history of hepatitis C
18. Natural course of chronic hepatitis C
19. Hepatitis C and hepatocellular carcinoma
20. Hepatitis C virus infection and hepatosplenic schistosomiasis
21. Hepatitis C virus infection in Schistosomiasis mansoni in Brazil
22. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni
23. Antibodies and viraemia in acute post-transfusion hepatitis C: A prospective study
24. A proposed system for the nomenclature of hepatitis C viral genotypes
25. Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices: A prospective controlled trial
26. Histological grading and staging of chronic hepatitis
27. The declining risk of post-transfusion hepatitis C virus infection
28. Post-transfusion hepatitis C virus infection
29. Hepatitis C virus infection in kidney transplant recipients
30. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin
31. Schistosomiasis, pathophysiology, diagnosis, and treatment
32. Immunological modulation and evasion by helminth parasites in human populations
33. Virological characterization and liver histology in HCV positive subjects with normal and elevated ALT levels
34. Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population
35. Assessment of hepatitis virus HCV RNA levels by quantitative competitive RNA polymerase chain reaction: High titers viremia correlates with advanced stage of disease
36. Hepatitis C viremia in chronic liver disease: Relationship to interferon- alpha or corticosteroid treatment
37. Quantification of hepatitis C virus by competitive reverse transcription- polymerase chain reaction: increase of the virus in advanced liver disease
38. Serum hepatitis C virus RNA quantity and histological features of hepatitis C carriers with persistently normal ALT levels
39. Hepatitis C virus type 1b (II) infection in France and Italy
40. Significance of serum hepatitis C RNA levels in chronic hepatitis C
41. Evaluation of liver histology, ALT elevation, and HCV RNA titer in patients with chronic hepatitis C
42. Hepatitis C virus genotype and RNA titre in the progression of type C chronic liver disease
43. Analysis of histopathological manifestations of chronic hepatitis virus infection with respect to virus genotype
44. Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection
45. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C
46. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C virus infection and in healthy anti- hepatitis C virus blood donors without viremia
47. Chronic human schistosomiasis mansoni. Pathology of the Disse's space
48. Human chronic mansonian schistosomiasis-cell proliferation and fiber formation in the hepatic sinusoidal wall: A morphometric, light and electron microscopy study
49. Resistance to reinfection in experimental murine schistosomiasis: Role of porto-hepatic hemodynamics